Back to School: How biopharma can reboot drug development. Access exclusive analysis here

La Jolla Pharmaceutical Corp. autoimmune/inflammation news

LJPC restructured and reduced its headcount to 129 from 153. The company had $38.7

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE